Autres langues Cipla Limited

Actions

CIPLA

INE059A01026

Marché Fermé - NSE India S.E. Autres places de cotation 13:40:47 29/04/2024			Varia. 5j.	Varia. 1 janv.
1 408 ^INR	-0,08 %		+3,92 %	+12,97 %

24/04	Les actions indiennes terminent en hausse en milieu de semaine alors que le conflit Iran-Israël s'apaise	MT
18/04	Le laboratoire indien Biocon développe sa propre version du Wegovy, l'essai clinique devrait avoir lieu l'année prochaine	RE

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Cipla Arm Completes Acquisition of Ivia's Cosmetics, Personal-Care Marketing Business	04:07
Indian Equities End Higher Midweek as Iran-Israel Conflict Subsides	24/04
Cipla Limited Receives Order from the GST Authority	19/04
India's Biocon developing its own version of Wegovy, clinical trial likely next year	18/04
Cipla's Consumer Healthcare Arm to Acquire Ivia's Cosmetics, Personal-Care Marketing Business	16/04
Indian Equities End Higher on Wednesday, Lifted Mainly by Metal Stocks	10/04
Cipla Receives US FDA Observations Following Patalganga Facility Inspection	05/04
Cipla Gets Regulatory Nod to Merge US-Based Subsidiaries	27/03
Cipla to Distribute Sanofi's CNS Product Line in India	27/03
Cipla Limited Appoints Rajeev Kumar Sinha as Senior Management Personnel and Global Chief Manufacturing Officer, Effective April 1, 2024	26/03
Cipla : Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in India	26/03
Sanofi India Limited, Sanofi Healthcare India Private Limited and Cipla Limited Announce an Exclusive Partnership	26/03
Losses Led by IT Drag Indian Equities on Tuesday	19/03
Cipla Limited Appoints Venkata Sai Mungara as Senior Management Personnel and Global Head - Supply Chain, Effective from 1 April 2024	15/03
Indian Equities Close with Marginal Gains on Tuesday as IT Stocks See Drop	12/03
Cipla Arm Completes Sale of Entire Stake in Wellthy	07/03
EXCLUSIVA-Eli Lilly podría lanzar un fármaco contra la obesidad en India el próximo año: presidente ejecutivo	28/02
India pharma companies develop versions of Wegovy to get in on weight-loss windfall	22/02
Indian Equities Close Higher Midweek, Led by Banking, IT Stocks	14/02
Indian drugmaker Lupin beats quarterly profit estimates on strong demand	07/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Cipla Limited

Actions

CIPLA

INE059A01026

Autres langues

Filtres